Research Profiles

Scientific Discovery

Chemo Decisions: Risk Benefit in Breast Cancer

Joseph Sparano, M.D., is a leading clinical oncologist who is working to tailor breast cancer treatment to individual patients. He is associate chair for disease-oriented research in the Eastern Cooperative Oncology Group (ECOG), which conducts clinical trials in all types of adult cancers and is one of the country�s largest cancer research organizations. He directs ECOG�s nationwide clinical trial to determine which women with early-stage breast cancer are likely to bene?t from chemotherapy intended to prevent cancer recurrence. Dr. Sparano is professor of medicine and of obstetrics & gynecology and women�s health and co-leader of the Breast Cancer Working Group of the Albert Einstein Cancer Center.

Joseph A. Sparano, M.D.

Adjunct Clinical Professor, Department of Oncology (Medical Oncology)
Adjunct Clinical Professor, Department of Medicine (Oncology & Hematology)
Adjunct Clinical Professor, Department of Obstetrics & Gynecology and Women's Health